SCHEMBL761332

SCHEMBL761332

C=C1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL762774 0.90
SCHEMBL28325272 0.89
SCHEMBL17307699 0.88 FKBP5 (0.43)
Bromide SCHEMBL19066250 0.88
Hydrochloric Acid SCHEMBL28236204 0.88
SCHEMBL10069784 0.88
SCHEMBL8736493 0.88
Ammonia Solution, Strong SCHEMBL28104524 0.88
Hydrochloric Acid SCHEMBL8003961 0.88
SCHEMBL31323236 0.81 FKBP5 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119656330-A Preparation of supermolecule nanoparticle for self-assembly of stimulus-responsive polypeptide coupled drug and application of supermolecule nanoparticle in brain tumor 北京理工大学 2025-03-21 CN claimed
CN-117088869-A 3CL protease inhibitor and preparation method and application thereof 上海翊石医药科技有限公司 2023-11-21 CN claimed
CN-114262290-A 4-methylene pyrrolidine-2-thioketone compound and synthesis method and application thereof 华东师范大学 2022-04-01 CN claimed
CN-113135956-A Mitochondrion targeted curcumin derivative and preparation method and medical application thereof 蔡世忠 2021-07-20 CN claimed
CN-112500419-A Epoxy fused 2-methylene pyrrolidine compound and preparation method thereof 浙大城市学院 2021-03-16 CN claimed
EP-3307724-B1 (Z)-2-(1H-INDOL-3-YL)-3-(ISOQUINOLIN-5-YL)ACRYLONITRILE DERIVATIVES AND RELATED COMPOUNDS WITH LYSOSOME INHIBITORY AND ANTI-MITOTIC ACTIVITY FOR TREATING HYPERPROLIFERATIVE DISEASES NAT UNIV SINGAPORE (SG) 2020-06-10 EP claimed
US-10308631-B2 Selective anti-cancer compounds NATIONAL UNIVERSITY OF SINGAPORE (SG) 2019-06-04 US claimed
US-20180179178-A1 SELECTIVE ANTI-CANCER COMPOUNDS NATIONAL UNIVERSITY OF SINGAPORE (SG) 2018-06-28 US claimed
EP-3307724-A1 SELECTIVE ANTI-CANCER COMPOUNDS National University of Singapore (SG) 2018-04-18 EP claimed
WO-2016200339-A1 SELECTIVE ANTI-CANCER COMPOUNDS NATIONAL UNIVERSITY OF SINGAPORE (SG) 2016-12-15 WO claimed
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO claimed
WO-2008020711-A1 QUINAZOLINE DERIVATIVE AS PHOSPHODIESTERASE INHIBITOR AND A PROCESS FOR PREPARING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2008-02-21 WO claimed
EP-0437185-B1 Pyrroline-resp. indoline containing phthalides CIBA GEIGY AG (CH) 1995-10-18 EP claimed
US-20250171456-A1 PSYCHEDELIC COMPOUNDS AND THEIR THERAPEUTIC USES CAAMTECH INC (US) 2025-05-29 US disclosed
CN-119656330-A Preparation of supermolecule nanoparticle for self-assembly of stimulus-responsive polypeptide coupled drug and application of supermolecule nanoparticle in brain tumor 北京理工大学 2025-03-21 CN disclosed
EP-4472629-A2 PSYCHEDELIC COMPOUNDS AND THEIR THERAPEUTIC USES Caamtech, Inc. (US) 2024-12-11 EP disclosed
US-4287199-A USEFUL AS ANTHELMINITICS BAYER AKTIENGESELLSCHAFT (DE) 1981-09-01 US disclosed
US-4260606-A ANTIDEPRESSANTS A. H. ROBINS COMPANY, INC. (US) 1981-04-07 US disclosed
US-4242261-A REACTING AN A,A-DIPHENYL-A-N-HETEROCYCLIC ACETAMIDE WITH BROMINE AND AN ALKALI METAL ALKOXIDE AND HEATING A. H. ROBINS COMPANY, INC. (US) 1980-12-30 US disclosed
EP-0010242-A1 Benzimidazolyl-2-carbamic acid esters, medicaments based thereon and process for their preparation BAYER AG (DE) 1980-04-30 EP disclosed